-
ADRX share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ADRX stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ADRX market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
About ADRX
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
-
ADRX market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
Smart score
Latest ADRX news
No recent TipRanks articles are available for ADRX
No recent press releases are available for ADRX
ADRX Financials
-
Total revenue: $3.45M (1Y), $746.00K (Q2)
Total Revenue decreased 99.67% since last year and decreased 65.14% since last quarter.
-
Net income: -$73.09M (1Y), -$25.76M (Q2)
Net Income decreased 217.0% since last year and decreased 13.64% since last quarter.
-
Earnings per share: -$0.72 (1Y), -$0.25 (Q2)
EPS decreased 184.13% since last year and decreased 13.62% since last quarter.
Key terms
ADRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ADRX Competitors
-
How competitors are chosen
ADRX's competitors are included in the Commercial Services sector and Miscellaneous Commercial Services group
-
ADRX market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.
